Scientific Sessions


10-yr follow-up results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients A Nationwide Cohort Study of Surveillance for Stage I Seminoma A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617 Choosing mastectomy over lumpectomy: Factors associated with surgical decisions in young women with breast cancer Clinical or survival benefit to routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial Efficacy of risk-reducing mastectomy (RRM) on overall survival (OS) in BRCA1/2-associated breast cancer (BC) patients For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery Impact of brachytherapy on local recurrence after sublobar resection: Results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small cell lung cancer (NSCLC) Impact of copayment elimination on annual and biennial screening mammography utilization among rural U.S. women Impact of oncology drug shortages Impact of socioeconomic status on extent of disease at diagnosis and cancer and ocular outcomes in retinoblastoma: A population-based analysis IQ change within three years of radiation therapy in pediatric brain tumor patients treated with proton beam radiation therapy versus photon radiation therapy Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial Neoadjuvant chemotherapy with or without preoperative irradiation in stage IIIA/N2 non-small cell lung cancer (NSCLC): A randomized phase III trial by the Swiss Group for Clinical Cancer Research (SAKK trial 16/00) Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors Predictive factors for chemotherapy feasibility in elderly patients with solid tumor: Results of GERCOR old prospective multicenter study Pregnancy outcome and survivorship in cancer patients Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023) Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates Screening for Lynch syndrome in unselected women with endometrial cancer

Blogs

Breaking news: Supreme Court votes to uphold Affordable Care Act Subsidies
by Christina Bach, MSW, LCSW, OSW-C
June 26, 2015

Related News

ASCO: Session Addresses Oral Chemotherapy Compliance

Jul 7, 2015

New strategies urged to overcome barriers that result in skipped doses and unfilled prescriptions


AHA: Increased Cancer Risk for Patients With Heart Failure

Nov 8, 2012

For patients with heart failure, incident cancer correlates with increased risk of death


AHA: Ideal Cardiovascular Health Tied to Cancer Risk

Nov 17, 2011

The number of ideal cardiovascular health metrics correlates inversely with cancer incidence


Frequently Asked Questions